van Werkum JW - Search Results

1

Monitoring antiplatelet therapy with point-of-care platelet function assays: a review of the evidence.

van Werkum JW, Hackeng CM, Smit JJ, Van't Hof AW, Verheugt FW, Ten Berg JM. van Werkum JW, et al. Among authors: van t hof aw. Future Cardiol. 2008 Jan;4(1):33-55. doi: 10.2217/14796678.4.1.33. Future Cardiol. 2008. PMID: 19804271

2

Point-of-care platelet function testing in patients undergoing PCI: between a rock and a hard place.

van Werkum JW, Hackeng CM, de Korte FI, Verheugt FW, Ten Berg JM. van Werkum JW, et al. Neth Heart J. 2007;15(9):299-305. doi: 10.1007/BF03086004. Neth Heart J. 2007. PMID: 18030318 Free PMC article.

3

The use of the VerifyNow system to monitor antiplatelet therapy: a review of the current evidence.

van Werkum JW, Harmsze AM, Elsenberg EH, Bouman HJ, ten Berg JM, Hackeng CM. van Werkum JW, et al. Platelets. 2008 Nov;19(7):479-88. doi: 10.1080/09537100802317918. Platelets. 2008. PMID: 18979359 Review.

4

Clopidogrel resistance: fact and fiction.

van Werkum JW, Heestermans AA, Deneer VH, Hackeng CM, Ten Berg JM. van Werkum JW, et al. Future Cardiol. 2006 Mar;2(2):215-28. doi: 10.2217/14796678.2.2.215. Future Cardiol. 2006. PMID: 19804078

5

Platelet function tests for the monitoring of P2Y12 inhibitors.

Breet NJ, van Werkum JW, Bouman HJ, Ten Berg JM, Hackeng CM. Breet NJ, et al. Among authors: van werkum jw. Expert Opin Med Diagn. 2010 May;4(3):251-65. doi: 10.1517/17530051003725139. Epub 2010 Apr 13. Expert Opin Med Diagn. 2010. PMID: 23488534

6

Inhibition of platelet function by abciximab or high-dose tirofiban in patients with STEMI undergoing primary PCI: a randomised trial.

van Werkum JW, Gerritsen WB, Kelder JC, Hackeng CM, Ernst SM, Deneer VH, Suttorp MJ, Rensing BJ, Plokker HW, Ten Berg JM. van Werkum JW, et al. Neth Heart J. 2007;15(11):375-81. doi: 10.1007/BF03086018. Neth Heart J. 2007. PMID: 18176639 Free PMC article.

7

Cangrelor increases the magnitude of platelet inhibition and reduces interindividual variability in clopidogrel-pretreated subjects.

Bouman HJ, van Werkum JW, Hackeng CM, Clappers N, Ten Berg JM. Bouman HJ, et al. Among authors: van werkum jw. Neth Heart J. 2009 May;17(5):195-8. doi: 10.1007/BF03086246. Neth Heart J. 2009. PMID: 19484155 Free PMC article.

8

Which platelet function test is suitable to monitor clopidogrel responsiveness? A pharmacokinetic analysis on the active metabolite of clopidogrel.

Bouman HJ, Parlak E, van Werkum JW, Breet NJ, ten Cate H, Hackeng CM, ten Berg JM, Taubert D. Bouman HJ, et al. Among authors: van werkum jw. J Thromb Haemost. 2010 Mar;8(3):482-8. doi: 10.1111/j.1538-7836.2009.03733.x. Epub 2009 Dec 21. J Thromb Haemost. 2010. PMID: 20040042 Free article.

9

High on-aspirin platelet reactivity as measured with aggregation-based, cyclooxygenase-1 inhibition sensitive platelet function tests is associated with the occurrence of atherothrombotic events.

Breet NJ, van Werkum JW, Bouman HJ, Kelder JC, Ten Berg JM, Hackeng CM. Breet NJ, et al. Among authors: van werkum jw. J Thromb Haemost. 2010 Oct;8(10):2140-8. doi: 10.1111/j.1538-7836.2010.04017.x. J Thromb Haemost. 2010. PMID: 20723029 Free article.

10

A case-control study on platelet reactivity in patients with coronary stent thrombosis.

Bouman HJ, van Werkum JW, Breet NJ, ten Cate H, Hackeng CM, ten Berg JM. Bouman HJ, et al. Among authors: van werkum jw. J Thromb Haemost. 2011 May;9(5):909-16. doi: 10.1111/j.1538-7836.2011.04255.x. J Thromb Haemost. 2011. PMID: 21382172 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

78 results

Search Page